Singapore Factory Output Falls 7.4 Percent Year-on-Year in June (Singapore)
This article was originally published in PharmAsia News
Singapore's pharmaceutical industry reduced production by 52.5 percent during the month of June 2007, mostly because many factories are revamping themselves for new pharmaceutical production mixes. This slow down shrunk Singapore's overall factory output by 7.4 percent this June compared to June 2006. Many economists believe Singapore's economy will expand between 5 percent and 7 percent this year and meet government targets despite the retraction in June. (Click here for more
You may also be interested in...
Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.
Akero’s FGF21 analog yields 63%-72% relative hepatic fat reduction in Phase IIa study; the company awaits biopsy data hoping to see a fibrotic benefit. Also, Genfit says COVID-19 pandemic should not significantly delay its Phase III NASH readout.
US Vice President Mike Pence and Medicare administrator Seema Verma want academic and university hospital laboratories to send their de-identified COVID-19 test data results, daily, to the Department of Health and Human Services. Commercial and private labs are exempt from the request, as they already share their coronavirus test results with the government.